Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,163,711
-
Total 13F shares
-
13,521,554
-
Share change
-
+888,777
-
Total reported value
-
$36,511,138
-
Price per share
-
$2.70
-
Number of holders
-
72
-
Value change
-
+$2,251,986
-
Number of buys
-
35
-
Number of sells
-
35
Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q1 2017
As of 31 Mar 2017,
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,521,554 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, NUMERIC INVESTORS LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, Casdin Capital, LLC, 683 Capital Management, LLC, and STATE STREET CORP.
This page lists
72
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.